Business Standard

Saturday, December 28, 2024 | 12:56 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Top Headlines: Pfizer Covid vax's 'India price', Twitter India seeks a week

Business Standard brings top headlines on Thursday

Pfizer vaccine
Premium

BS Web Team New Delhi
US pharmaceutical major Pfizer may price its mRNA-based Covid-19 vaccine, co-developed by BioNTech, below $10 (about Rs 730) a dose in India. Twitter said it was making every effort to comply with the new guidelines and will provide the details of its Chief Compliance Officer within a week. Business Standard brings top headlines on Thursday.

Pfizer's Covid-19 vaccine may cost less than $10 a dose in India

US pharmaceutical major Pfizer may price its mRNA-based Covid-19 vaccine, co-developed by BioNTech, below $10

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in